Home > Insider Trading > Filing (0001843575-23-000002)

Filing Details

Accession Number:: 0001843575-23-000002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-02 21:02:25
Reporting Period:: 2023-02-28

Accepted Time:: 2023-03-02 21:02:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1785345	Landos Biopharma Inc.	LABP	Pharmaceutical Preparations (2834)	815085535

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1843575	Josep Bassaganya-Riera	1800 Kraft Drive Suite 100 Blacksburg VA 24060		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-02-28	3,470,736	$0.00	No	4	S	Indirect	by trust
Common Stock	Disposition	2023-02-28	467,306	$0.00	No	4	S	Indirect	by GRAT
Common Stock	Disposition	2023-02-28	496,527	$0.00	No	4	S	Indirect	by GRAT
Common Stock	Disposition	2023-02-28	500,000	$0.00	No	4	S	Indirect	by GRAT
Common Stock	Disposition	2023-02-28	786,299	$0.00	No	4	S	Indirect	by family trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	by trust
No	4	S	Indirect	by GRAT
No	4	S	Indirect	by GRAT
No	4	S	Indirect	by GRAT
No	4	S	Indirect	by family trust

Footnotes

All of the shares reported as sold on this Form 4 were sold to the issuer for aggregate consideration of $1,888,814.77 in cash plus certain intellectual property rights and other assets, as part of the private transaction described in the issuer's Current Report on Form 8-K filed on February 28, 2023 with the Securities and Exchange Commission.
These shares were held by the Josep Bassaganya-Riera Revocable Trust dated April 9, 2018, as amended (the "2018 Trust"). The Reporting Person is the sole trustee of the 2018 Trust and the beneficiaries are the Reporting Person's immediate family members. The Reporting Person disclaimed beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
These shares were held by the Josep Bassaganya-Riera Grantor Retained Annuity Trust No. 1 dated June 28, 2018 (the "2018 GRAT"). The Reporting Person is the sole trustee of the 2018 GRAT and the beneficiaries are the Reporting Person's immediate family members. The Reporting Person disclaimed beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
These shares were held by the Josep Bassaganya-Riera Grantor Retained Annuity Trust No. 2 dated March 26, 2019 (the "2019 GRAT"). The Reporting Person is the sole trustee of the 2019 GRAT and the beneficiaries are the Reporting Person's immediate family members. The Reporting Person disclaimed beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
These shares were held by the Josep Bassaganya-Riera Grantor Retained Annuity Trust No. 3 dated August 3, 2022 (the "2022 GRAT"). The Reporting Person is the sole trustee of the 2022 GRAT and the beneficiaries are the Reporting Person's immediate family members. The Reporting Person disclaimed beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
These shares were held by the Raquel Hontecillas-Magarzo Irrevocable Family Trust dated October 1, 2021 (the "2021 Family Trust"). The Reporting Person is the sole trustee of the 2021 Family Trust and the beneficiaries are the Reporting Person and the Reporting Person's immediate family members. The Reporting Person disclaimed beneficial ownership of these securities, except to the extent of his pecuniary interest therein.